Chikungunya virus (CHIKV) is a mosquito-borne alphavirus that recently re-emerged in
many parts of the world causing large-scale outbreaks. CHIKV infection presents as a febrile …

Re-emergence of chikungunya virus, a mosquito-transmitted pathogen, is of serious public
health concern. In the past 15 years, after decades of infrequent, sporadic outbreaks, the …

Chikungunya virus (CHIKV) is the aetiological agent of the mosquito-borne disease
chikungunya fever, a debilitating arthritic disease that, during the past 7 years, has caused …

Chikungunya virus (CHIKV) is a mosquito-transmitted alphavirus belonging to the
Togaviridae family, first isolated in Tanzania in 1952. The main vectors are mosquitoes from …

Beginning in 2004, chikungunya virus (CHIKV) went from an endemic pathogen limited to
Africa and Asia that caused periodic outbreaks to a global pathogen. Given that outbreaks …

Inactivated vaccines have been used for over a century to induce protection against viral
pathogens. This established approach of vaccine production is relatively straightforward to …

Traditionally, vaccine development involves tradeoffs between immunogenicity and safety.
Live-attenuated vaccines typically offer rapid and durable immunity but have reduced safety …

Chikungunya virus (CHIKV) is a reemerging mosquito-borne alphavirus that has caused
severe epidemics in Africa and Asia and occasionally in Europe. As of today, there is no …

Chikungunya virus (CHIKV) is a re-emergent arthropod-borne virus (arbovirus) that causes a
disease characterized primarily by fever, rash and severe persistent polyarthralgia. In the …

Chikungunya fever (CHIKF) is an acute infectious disease that is mediated by the mosquito-
transmitted chikungunya virus (CHIKV). People infected with CHIKV may experience high …